nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—SCN5A—dilated cardiomyopathy	0.348	1	CbGaD
Zonisamide—CA14—Furosemide—dilated cardiomyopathy	0.0571	0.128	CbGbCtD
Zonisamide—CA5A—Furosemide—dilated cardiomyopathy	0.0542	0.121	CbGbCtD
Zonisamide—CA6—Furosemide—dilated cardiomyopathy	0.0542	0.121	CbGbCtD
Zonisamide—CA5B—Furosemide—dilated cardiomyopathy	0.0472	0.106	CbGbCtD
Zonisamide—CA7—Furosemide—dilated cardiomyopathy	0.0472	0.106	CbGbCtD
Zonisamide—CA12—Furosemide—dilated cardiomyopathy	0.0405	0.0906	CbGbCtD
Zonisamide—CA9—Furosemide—dilated cardiomyopathy	0.0405	0.0906	CbGbCtD
Zonisamide—CA1—Furosemide—dilated cardiomyopathy	0.0379	0.0848	CbGbCtD
Zonisamide—CA4—Furosemide—dilated cardiomyopathy	0.0357	0.0797	CbGbCtD
Zonisamide—CA2—Furosemide—dilated cardiomyopathy	0.0328	0.0733	CbGbCtD
Zonisamide—CACNA1G—sinoatrial node—dilated cardiomyopathy	0.0117	0.171	CbGeAlD
Zonisamide—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0116	0.169	CbGeAlD
Zonisamide—SCN5A—endocardium—dilated cardiomyopathy	0.00596	0.0871	CbGeAlD
Zonisamide—CA5B—sinoatrial node—dilated cardiomyopathy	0.00583	0.0852	CbGeAlD
Zonisamide—SCN5A—sinoatrial node—dilated cardiomyopathy	0.00565	0.0826	CbGeAlD
Zonisamide—CA3—pericardium—dilated cardiomyopathy	0.00346	0.0506	CbGeAlD
Zonisamide—Hydronephrosis—Furosemide—dilated cardiomyopathy	0.00263	0.0406	CcSEcCtD
Zonisamide—SCN4B—cardiac ventricle—dilated cardiomyopathy	0.00155	0.0227	CbGeAlD
Zonisamide—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00151	0.0233	CcSEcCtD
Zonisamide—SCN4B—myocardium—dilated cardiomyopathy	0.00146	0.0213	CbGeAlD
Zonisamide—SCN2B—heart—dilated cardiomyopathy	0.00144	0.021	CbGeAlD
Zonisamide—SCN1B—heart—dilated cardiomyopathy	0.0013	0.019	CbGeAlD
Zonisamide—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.00128	0.0197	CcSEcCtD
Zonisamide—CA8—heart—dilated cardiomyopathy	0.00122	0.0178	CbGeAlD
Zonisamide—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00109	0.0169	CcSEcCtD
Zonisamide—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00106	0.0163	CcSEcCtD
Zonisamide—CA13—heart—dilated cardiomyopathy	0.00104	0.0153	CbGeAlD
Zonisamide—SCN4B—heart—dilated cardiomyopathy	0.00102	0.0149	CbGeAlD
Zonisamide—Flank pain—Lisinopril—dilated cardiomyopathy	0.00094	0.0145	CcSEcCtD
Zonisamide—CA11—heart—dilated cardiomyopathy	0.000877	0.0128	CbGeAlD
Zonisamide—SCN4B—cardiac atrium—dilated cardiomyopathy	0.000871	0.0127	CbGeAlD
Zonisamide—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.000852	0.0131	CcSEcCtD
Zonisamide—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00083	0.0128	CcSEcCtD
Zonisamide—Drug eruption—Furosemide—dilated cardiomyopathy	0.00082	0.0127	CcSEcCtD
Zonisamide—CA3—cardiac ventricle—dilated cardiomyopathy	0.000815	0.0119	CbGeAlD
Zonisamide—CA3—myocardium—dilated cardiomyopathy	0.000767	0.0112	CbGeAlD
Zonisamide—CA11—cardiac atrium—dilated cardiomyopathy	0.00075	0.011	CbGeAlD
Zonisamide—CA14—cardiac ventricle—dilated cardiomyopathy	0.00074	0.0108	CbGeAlD
Zonisamide—Ataxia—Spironolactone—dilated cardiomyopathy	0.000633	0.00977	CcSEcCtD
Zonisamide—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.000628	0.00969	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000606	0.00936	CcSEcCtD
Zonisamide—Gastritis—Spironolactone—dilated cardiomyopathy	0.000596	0.00919	CcSEcCtD
Zonisamide—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.000582	0.00899	CcSEcCtD
Zonisamide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000576	0.00889	CcSEcCtD
Zonisamide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000574	0.00886	CcSEcCtD
Zonisamide—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000536	0.00827	CcSEcCtD
Zonisamide—CA3—heart—dilated cardiomyopathy	0.000535	0.00782	CbGeAlD
Zonisamide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000514	0.00794	CcSEcCtD
Zonisamide—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.000512	0.00789	CcSEcCtD
Zonisamide—Renal failure—Spironolactone—dilated cardiomyopathy	0.00051	0.00787	CcSEcCtD
Zonisamide—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.000502	0.00733	CbGeAlD
Zonisamide—CA14—heart—dilated cardiomyopathy	0.000486	0.0071	CbGeAlD
Zonisamide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000484	0.00747	CcSEcCtD
Zonisamide—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000482	0.00744	CcSEcCtD
Zonisamide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000474	0.00731	CcSEcCtD
Zonisamide—SCN5A—myocardium—dilated cardiomyopathy	0.000472	0.00689	CbGeAlD
Zonisamide—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000464	0.00715	CcSEcCtD
Zonisamide—CA3—cardiac atrium—dilated cardiomyopathy	0.000458	0.00669	CbGeAlD
Zonisamide—Urine output increased—Furosemide—dilated cardiomyopathy	0.000456	0.00704	CcSEcCtD
Zonisamide—Bladder pain—Furosemide—dilated cardiomyopathy	0.000456	0.00704	CcSEcCtD
Zonisamide—CACNA1H—heart—dilated cardiomyopathy	0.000446	0.00652	CbGeAlD
Zonisamide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00044	0.0068	CcSEcCtD
Zonisamide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000431	0.00665	CcSEcCtD
Zonisamide—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000428	0.0066	CcSEcCtD
Zonisamide—SCN4A—heart—dilated cardiomyopathy	0.000425	0.00621	CbGeAlD
Zonisamide—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000423	0.00653	CcSEcCtD
Zonisamide—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000419	0.00647	CcSEcCtD
Zonisamide—Polyuria—Furosemide—dilated cardiomyopathy	0.000417	0.00644	CcSEcCtD
Zonisamide—CA14—cardiac atrium—dilated cardiomyopathy	0.000416	0.00607	CbGeAlD
Zonisamide—Cough increased—Lisinopril—dilated cardiomyopathy	0.000414	0.00638	CcSEcCtD
Zonisamide—Alopecia—Spironolactone—dilated cardiomyopathy	0.000412	0.00635	CcSEcCtD
Zonisamide—Deafness—Furosemide—dilated cardiomyopathy	0.000409	0.00632	CcSEcCtD
Zonisamide—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000403	0.00622	CcSEcCtD
Zonisamide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00039	0.00602	CcSEcCtD
Zonisamide—Thirst—Furosemide—dilated cardiomyopathy	0.000385	0.00594	CcSEcCtD
Zonisamide—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000383	0.00591	CcSEcCtD
Zonisamide—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000379	0.00584	CcSEcCtD
Zonisamide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000376	0.0058	CcSEcCtD
Zonisamide—MAOB—cardiac ventricle—dilated cardiomyopathy	0.000371	0.00542	CbGeAlD
Zonisamide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000368	0.00567	CcSEcCtD
Zonisamide—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000368	0.00567	CcSEcCtD
Zonisamide—Malaise—Spironolactone—dilated cardiomyopathy	0.000366	0.00564	CcSEcCtD
Zonisamide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000363	0.0056	CcSEcCtD
Zonisamide—CA4—cardiac ventricle—dilated cardiomyopathy	0.000357	0.00522	CbGeAlD
Zonisamide—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000357	0.00552	CcSEcCtD
Zonisamide—Photophobia—Lisinopril—dilated cardiomyopathy	0.000355	0.00549	CcSEcCtD
Zonisamide—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000355	0.00549	CcSEcCtD
Zonisamide—Irritability—Furosemide—dilated cardiomyopathy	0.00035	0.00539	CcSEcCtD
Zonisamide—MAOB—myocardium—dilated cardiomyopathy	0.000349	0.0051	CbGeAlD
Zonisamide—Urinary retention—Furosemide—dilated cardiomyopathy	0.000348	0.00537	CcSEcCtD
Zonisamide—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000343	0.0053	CcSEcCtD
Zonisamide—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000342	0.00528	CcSEcCtD
Zonisamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.000341	0.00526	CcSEcCtD
Zonisamide—Dehydration—Furosemide—dilated cardiomyopathy	0.000341	0.00526	CcSEcCtD
Zonisamide—CA5B—heart—dilated cardiomyopathy	0.00034	0.00497	CbGeAlD
Zonisamide—CA4—myocardium—dilated cardiomyopathy	0.000336	0.00491	CbGeAlD
Zonisamide—Confusional state—Spironolactone—dilated cardiomyopathy	0.000334	0.00515	CcSEcCtD
Zonisamide—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000333	0.00514	CcSEcCtD
Zonisamide—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000332	0.00512	CcSEcCtD
Zonisamide—SCN3A—heart—dilated cardiomyopathy	0.00033	0.00483	CbGeAlD
Zonisamide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00033	0.00509	CcSEcCtD
Zonisamide—SCN5A—heart—dilated cardiomyopathy	0.000329	0.00481	CbGeAlD
Zonisamide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000324	0.005	CcSEcCtD
Zonisamide—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000323	0.00498	CcSEcCtD
Zonisamide—MAOA—cardiac ventricle—dilated cardiomyopathy	0.000317	0.00462	CbGeAlD
Zonisamide—AOX1—heart—dilated cardiomyopathy	0.000316	0.00462	CbGeAlD
Zonisamide—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000313	0.00484	CcSEcCtD
Zonisamide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00031	0.00479	CcSEcCtD
Zonisamide—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00031	0.00478	CcSEcCtD
Zonisamide—Eczema—Lisinopril—dilated cardiomyopathy	0.000306	0.00472	CcSEcCtD
Zonisamide—CA1—heart—dilated cardiomyopathy	0.0003	0.00439	CbGeAlD
Zonisamide—Injury—Lisinopril—dilated cardiomyopathy	0.000299	0.00461	CcSEcCtD
Zonisamide—MAOA—myocardium—dilated cardiomyopathy	0.000298	0.00435	CbGeAlD
Zonisamide—CA2—cardiac ventricle—dilated cardiomyopathy	0.000296	0.00433	CbGeAlD
Zonisamide—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000296	0.00457	CcSEcCtD
Zonisamide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000294	0.00454	CcSEcCtD
Zonisamide—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000292	0.00451	CcSEcCtD
Zonisamide—CA5B—cardiac atrium—dilated cardiomyopathy	0.000291	0.00425	CbGeAlD
Zonisamide—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00029	0.00448	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000286	0.00441	CcSEcCtD
Zonisamide—Arthritis—Lisinopril—dilated cardiomyopathy	0.000283	0.00436	CcSEcCtD
Zonisamide—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000282	0.00412	CbGeAlD
Zonisamide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000282	0.00435	CcSEcCtD
Zonisamide—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00028	0.00433	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00028	0.00432	CcSEcCtD
Zonisamide—CA2—myocardium—dilated cardiomyopathy	0.000279	0.00407	CbGeAlD
Zonisamide—Renal failure—Furosemide—dilated cardiomyopathy	0.000277	0.00428	CcSEcCtD
Zonisamide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000276	0.00426	CcSEcCtD
Zonisamide—Diplopia—Lisinopril—dilated cardiomyopathy	0.000275	0.00424	CcSEcCtD
Zonisamide—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000275	0.00424	CcSEcCtD
Zonisamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000273	0.00421	CcSEcCtD
Zonisamide—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000273	0.00421	CcSEcCtD
Zonisamide—Sweating—Furosemide—dilated cardiomyopathy	0.000271	0.00418	CcSEcCtD
Zonisamide—AOX1—cardiac atrium—dilated cardiomyopathy	0.00027	0.00395	CbGeAlD
Zonisamide—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000267	0.00412	CcSEcCtD
Zonisamide—Face oedema—Lisinopril—dilated cardiomyopathy	0.000265	0.00409	CcSEcCtD
Zonisamide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000263	0.00406	CcSEcCtD
Zonisamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000263	0.00406	CcSEcCtD
Zonisamide—Irritability—Lisinopril—dilated cardiomyopathy	0.000262	0.00405	CcSEcCtD
Zonisamide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000262	0.00404	CcSEcCtD
Zonisamide—Ataxia—Lisinopril—dilated cardiomyopathy	0.000258	0.00399	CcSEcCtD
Zonisamide—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000257	0.00397	CcSEcCtD
Zonisamide—Dehydration—Lisinopril—dilated cardiomyopathy	0.000256	0.00394	CcSEcCtD
Zonisamide—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00025	0.00386	CcSEcCtD
Zonisamide—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000248	0.00383	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000247	0.00382	CcSEcCtD
Zonisamide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000244	0.00376	CcSEcCtD
Zonisamide—MAOB—heart—dilated cardiomyopathy	0.000244	0.00356	CbGeAlD
Zonisamide—Gastritis—Lisinopril—dilated cardiomyopathy	0.000243	0.00375	CcSEcCtD
Zonisamide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00024	0.0037	CcSEcCtD
Zonisamide—Influenza—Lisinopril—dilated cardiomyopathy	0.000238	0.00367	CcSEcCtD
Zonisamide—Eye disorder—Furosemide—dilated cardiomyopathy	0.000237	0.00365	CcSEcCtD
Zonisamide—Tinnitus—Furosemide—dilated cardiomyopathy	0.000236	0.00365	CcSEcCtD
Zonisamide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000235	0.00363	CcSEcCtD
Zonisamide—CA4—heart—dilated cardiomyopathy	0.000235	0.00343	CbGeAlD
Zonisamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000234	0.00361	CcSEcCtD
Zonisamide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000233	0.00359	CcSEcCtD
Zonisamide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000229	0.00353	CcSEcCtD
Zonisamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000226	0.00349	CcSEcCtD
Zonisamide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000226	0.00348	CcSEcCtD
Zonisamide—Dysuria—Lisinopril—dilated cardiomyopathy	0.000222	0.00343	CcSEcCtD
Zonisamide—Malnutrition—Furosemide—dilated cardiomyopathy	0.000221	0.0034	CcSEcCtD
Zonisamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000219	0.00338	CcSEcCtD
Zonisamide—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000219	0.00338	CcSEcCtD
Zonisamide—Flatulence—Furosemide—dilated cardiomyopathy	0.000217	0.00335	CcSEcCtD
Zonisamide—Weight increased—Lisinopril—dilated cardiomyopathy	0.000216	0.00334	CcSEcCtD
Zonisamide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000216	0.00333	CcSEcCtD
Zonisamide—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000215	0.00332	CcSEcCtD
Zonisamide—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000213	0.00329	CcSEcCtD
Zonisamide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000212	0.00327	CcSEcCtD
Zonisamide—Depression—Lisinopril—dilated cardiomyopathy	0.000211	0.00326	CcSEcCtD
Zonisamide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00021	0.00325	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00021	0.00324	CcSEcCtD
Zonisamide—Rash—Spironolactone—dilated cardiomyopathy	0.000209	0.00322	CcSEcCtD
Zonisamide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000208	0.00322	CcSEcCtD
Zonisamide—MAOB—cardiac atrium—dilated cardiomyopathy	0.000208	0.00304	CbGeAlD
Zonisamide—Renal failure—Lisinopril—dilated cardiomyopathy	0.000208	0.00321	CcSEcCtD
Zonisamide—MAOA—heart—dilated cardiomyopathy	0.000208	0.00304	CbGeAlD
Zonisamide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000208	0.0032	CcSEcCtD
Zonisamide—Headache—Spironolactone—dilated cardiomyopathy	0.000207	0.0032	CcSEcCtD
Zonisamide—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000206	0.00318	CcSEcCtD
Zonisamide—Anaemia—Furosemide—dilated cardiomyopathy	0.000204	0.00315	CcSEcCtD
Zonisamide—Sweating—Lisinopril—dilated cardiomyopathy	0.000203	0.00313	CcSEcCtD
Zonisamide—Agitation—Furosemide—dilated cardiomyopathy	0.000203	0.00313	CcSEcCtD
Zonisamide—Haematuria—Lisinopril—dilated cardiomyopathy	0.000202	0.00312	CcSEcCtD
Zonisamide—CA4—cardiac atrium—dilated cardiomyopathy	0.000201	0.00293	CbGeAlD
Zonisamide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.0002	0.00309	CcSEcCtD
Zonisamide—Vertigo—Furosemide—dilated cardiomyopathy	0.000198	0.00306	CcSEcCtD
Zonisamide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000198	0.00305	CcSEcCtD
Zonisamide—Leukopenia—Furosemide—dilated cardiomyopathy	0.000197	0.00305	CcSEcCtD
Zonisamide—Nausea—Spironolactone—dilated cardiomyopathy	0.000197	0.00303	CcSEcCtD
Zonisamide—CA2—heart—dilated cardiomyopathy	0.000195	0.00284	CbGeAlD
Zonisamide—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000194	0.00299	CcSEcCtD
Zonisamide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000191	0.00294	CcSEcCtD
Zonisamide—Hallucination—Lisinopril—dilated cardiomyopathy	0.000189	0.00292	CcSEcCtD
Zonisamide—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000189	0.00291	CcSEcCtD
Zonisamide—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000188	0.0029	CcSEcCtD
Zonisamide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000187	0.00289	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000187	0.00288	CcSEcCtD
Zonisamide—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000186	0.00288	CcSEcCtD
Zonisamide—Dry mouth—Furosemide—dilated cardiomyopathy	0.000184	0.00283	CcSEcCtD
Zonisamide—Confusional state—Furosemide—dilated cardiomyopathy	0.000182	0.0028	CcSEcCtD
Zonisamide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00018	0.00277	CcSEcCtD
Zonisamide—MAOA—cardiac atrium—dilated cardiomyopathy	0.000178	0.0026	CbGeAlD
Zonisamide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000177	0.00274	CcSEcCtD
Zonisamide—Shock—Furosemide—dilated cardiomyopathy	0.000177	0.00273	CcSEcCtD
Zonisamide—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000177	0.00272	CcSEcCtD
Zonisamide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000176	0.00272	CcSEcCtD
Zonisamide—Skin disorder—Furosemide—dilated cardiomyopathy	0.000175	0.0027	CcSEcCtD
Zonisamide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000174	0.00269	CcSEcCtD
Zonisamide—Anorexia—Furosemide—dilated cardiomyopathy	0.000172	0.00265	CcSEcCtD
Zonisamide—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000171	0.00264	CcSEcCtD
Zonisamide—Hypotension—Furosemide—dilated cardiomyopathy	0.000168	0.0026	CcSEcCtD
Zonisamide—Alopecia—Lisinopril—dilated cardiomyopathy	0.000168	0.00259	CcSEcCtD
Zonisamide—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000167	0.00257	CcSEcCtD
Zonisamide—CA2—cardiac atrium—dilated cardiomyopathy	0.000166	0.00243	CbGeAlD
Zonisamide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000166	0.00255	CcSEcCtD
Zonisamide—Flatulence—Lisinopril—dilated cardiomyopathy	0.000163	0.00252	CcSEcCtD
Zonisamide—Tension—Lisinopril—dilated cardiomyopathy	0.000162	0.00251	CcSEcCtD
Zonisamide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000162	0.0025	CcSEcCtD
Zonisamide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000162	0.00249	CcSEcCtD
Zonisamide—Nervousness—Lisinopril—dilated cardiomyopathy	0.000161	0.00248	CcSEcCtD
Zonisamide—Somnolence—Furosemide—dilated cardiomyopathy	0.00016	0.00247	CcSEcCtD
Zonisamide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000159	0.00246	CcSEcCtD
Zonisamide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000157	0.00241	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000155	0.0024	CcSEcCtD
Zonisamide—Fatigue—Furosemide—dilated cardiomyopathy	0.000155	0.0024	CcSEcCtD
Zonisamide—Tremor—Lisinopril—dilated cardiomyopathy	0.000155	0.00239	CcSEcCtD
Zonisamide—Constipation—Furosemide—dilated cardiomyopathy	0.000154	0.00238	CcSEcCtD
Zonisamide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000154	0.00237	CcSEcCtD
Zonisamide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000153	0.00236	CcSEcCtD
Zonisamide—Malaise—Lisinopril—dilated cardiomyopathy	0.000149	0.0023	CcSEcCtD
Zonisamide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000149	0.00229	CcSEcCtD
Zonisamide—Syncope—Lisinopril—dilated cardiomyopathy	0.000148	0.00229	CcSEcCtD
Zonisamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000148	0.00229	CcSEcCtD
Zonisamide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000148	0.00229	CcSEcCtD
Zonisamide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000147	0.00227	CcSEcCtD
Zonisamide—Palpitations—Lisinopril—dilated cardiomyopathy	0.000146	0.00226	CcSEcCtD
Zonisamide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000145	0.00224	CcSEcCtD
Zonisamide—Cough—Lisinopril—dilated cardiomyopathy	0.000144	0.00223	CcSEcCtD
Zonisamide—Urticaria—Furosemide—dilated cardiomyopathy	0.000143	0.00221	CcSEcCtD
Zonisamide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000142	0.0022	CcSEcCtD
Zonisamide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000142	0.0022	CcSEcCtD
Zonisamide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000141	0.00217	CcSEcCtD
Zonisamide—Myalgia—Lisinopril—dilated cardiomyopathy	0.000141	0.00217	CcSEcCtD
Zonisamide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000141	0.00217	CcSEcCtD
Zonisamide—Anxiety—Lisinopril—dilated cardiomyopathy	0.00014	0.00217	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00014	0.00216	CcSEcCtD
Zonisamide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000139	0.00215	CcSEcCtD
Zonisamide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000138	0.00213	CcSEcCtD
Zonisamide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000136	0.0021	CcSEcCtD
Zonisamide—Oedema—Lisinopril—dilated cardiomyopathy	0.000135	0.00208	CcSEcCtD
Zonisamide—Infection—Lisinopril—dilated cardiomyopathy	0.000134	0.00207	CcSEcCtD
Zonisamide—Shock—Lisinopril—dilated cardiomyopathy	0.000133	0.00205	CcSEcCtD
Zonisamide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000133	0.00205	CcSEcCtD
Zonisamide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000132	0.00204	CcSEcCtD
Zonisamide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000132	0.00203	CcSEcCtD
Zonisamide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000131	0.00202	CcSEcCtD
Zonisamide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000131	0.00201	CcSEcCtD
Zonisamide—Asthenia—Furosemide—dilated cardiomyopathy	0.000129	0.00199	CcSEcCtD
Zonisamide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000129	0.00199	CcSEcCtD
Zonisamide—Pruritus—Furosemide—dilated cardiomyopathy	0.000127	0.00197	CcSEcCtD
Zonisamide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000126	0.00195	CcSEcCtD
Zonisamide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000123	0.0019	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000123	0.0019	CcSEcCtD
Zonisamide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000122	0.00189	CcSEcCtD
Zonisamide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000121	0.00187	CcSEcCtD
Zonisamide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00012	0.00186	CcSEcCtD
Zonisamide—Somnolence—Lisinopril—dilated cardiomyopathy	0.00012	0.00185	CcSEcCtD
Zonisamide—Dizziness—Furosemide—dilated cardiomyopathy	0.000119	0.00184	CcSEcCtD
Zonisamide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000119	0.00183	CcSEcCtD
Zonisamide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000117	0.00181	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000117	0.0018	CcSEcCtD
Zonisamide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000116	0.0018	CcSEcCtD
Zonisamide—Constipation—Lisinopril—dilated cardiomyopathy	0.000116	0.00178	CcSEcCtD
Zonisamide—Vomiting—Furosemide—dilated cardiomyopathy	0.000114	0.00177	CcSEcCtD
Zonisamide—Rash—Furosemide—dilated cardiomyopathy	0.000114	0.00175	CcSEcCtD
Zonisamide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000113	0.00175	CcSEcCtD
Zonisamide—Headache—Furosemide—dilated cardiomyopathy	0.000113	0.00174	CcSEcCtD
Zonisamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000111	0.00172	CcSEcCtD
Zonisamide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00011	0.0017	CcSEcCtD
Zonisamide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000107	0.00166	CcSEcCtD
Zonisamide—Nausea—Furosemide—dilated cardiomyopathy	0.000107	0.00165	CcSEcCtD
Zonisamide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000107	0.00165	CcSEcCtD
Zonisamide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000107	0.00165	CcSEcCtD
Zonisamide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	9.95e-05	0.00154	CcSEcCtD
Zonisamide—Asthenia—Lisinopril—dilated cardiomyopathy	9.69e-05	0.0015	CcSEcCtD
Zonisamide—Pruritus—Lisinopril—dilated cardiomyopathy	9.56e-05	0.00147	CcSEcCtD
Zonisamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	9.24e-05	0.00143	CcSEcCtD
Zonisamide—Dizziness—Lisinopril—dilated cardiomyopathy	8.93e-05	0.00138	CcSEcCtD
Zonisamide—Vomiting—Lisinopril—dilated cardiomyopathy	8.59e-05	0.00133	CcSEcCtD
Zonisamide—Rash—Lisinopril—dilated cardiomyopathy	8.52e-05	0.00131	CcSEcCtD
Zonisamide—Dermatitis—Lisinopril—dilated cardiomyopathy	8.51e-05	0.00131	CcSEcCtD
Zonisamide—Headache—Lisinopril—dilated cardiomyopathy	8.46e-05	0.00131	CcSEcCtD
Zonisamide—Nausea—Lisinopril—dilated cardiomyopathy	8.02e-05	0.00124	CcSEcCtD
Zonisamide—SCN1A—Axon guidance—PSEN2—dilated cardiomyopathy	7.3e-05	0.00102	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—RAF1—dilated cardiomyopathy	7.26e-05	0.00101	CbGpPWpGaD
Zonisamide—CA14—Metabolism—TAZ—dilated cardiomyopathy	7.24e-05	0.00101	CbGpPWpGaD
Zonisamide—CA6—Metabolism—TAZ—dilated cardiomyopathy	7.05e-05	0.000983	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—TAZ—dilated cardiomyopathy	7.05e-05	0.000983	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ANKRD1—dilated cardiomyopathy	7e-05	0.000976	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ANKRD1—dilated cardiomyopathy	7e-05	0.000976	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—ITGB1—dilated cardiomyopathy	6.97e-05	0.000971	CbGpPWpGaD
Zonisamide—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	6.83e-05	0.000952	CbGpPWpGaD
Zonisamide—SCN11A—L1CAM interactions—EGFR—dilated cardiomyopathy	6.74e-05	0.000939	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—TAZ—dilated cardiomyopathy	6.59e-05	0.000917	CbGpPWpGaD
Zonisamide—CA7—Metabolism—TAZ—dilated cardiomyopathy	6.59e-05	0.000917	CbGpPWpGaD
Zonisamide—CA14—Metabolism—SDHA—dilated cardiomyopathy	6.55e-05	0.000912	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ANKRD1—dilated cardiomyopathy	6.49e-05	0.000904	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—SDHA—dilated cardiomyopathy	6.38e-05	0.000889	CbGpPWpGaD
Zonisamide—CA6—Metabolism—SDHA—dilated cardiomyopathy	6.38e-05	0.000889	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—ABCC9—dilated cardiomyopathy	6.33e-05	0.000882	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—PSEN2—dilated cardiomyopathy	6.18e-05	0.000862	CbGpPWpGaD
Zonisamide—CA12—Metabolism—TAZ—dilated cardiomyopathy	6.1e-05	0.00085	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—RAF1—dilated cardiomyopathy	6.09e-05	0.000849	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—RAF1—dilated cardiomyopathy	6.09e-05	0.000849	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	6.08e-05	0.000847	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—ACTN2—dilated cardiomyopathy	6.07e-05	0.000845	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—PSEN2—dilated cardiomyopathy	5.99e-05	0.000834	CbGpPWpGaD
Zonisamide—CA7—Metabolism—SDHA—dilated cardiomyopathy	5.96e-05	0.00083	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—SDHA—dilated cardiomyopathy	5.96e-05	0.00083	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—RAC1—dilated cardiomyopathy	5.91e-05	0.000824	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	5.88e-05	0.000819	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—EGFR—dilated cardiomyopathy	5.85e-05	0.000816	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—EGFR—dilated cardiomyopathy	5.85e-05	0.000816	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—PSEN2—dilated cardiomyopathy	5.63e-05	0.000784	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—RAC1—dilated cardiomyopathy	5.6e-05	0.000781	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—RAF1—dilated cardiomyopathy	5.57e-05	0.000776	CbGpPWpGaD
Zonisamide—CA12—Metabolism—SDHA—dilated cardiomyopathy	5.52e-05	0.000769	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—ITGB1—dilated cardiomyopathy	5.42e-05	0.000755	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—PSEN2—dilated cardiomyopathy	5.41e-05	0.000753	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	5.41e-05	0.000753	CbGpPWpGaD
Zonisamide—SCN4B—Axon guidance—EGFR—dilated cardiomyopathy	5.35e-05	0.000746	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	5.27e-05	0.000735	CbGpPWpGaD
Zonisamide—CA13—Metabolism—GPX1—dilated cardiomyopathy	5.25e-05	0.000732	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—ITGB1—dilated cardiomyopathy	5.25e-05	0.000731	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—ITGB1—dilated cardiomyopathy	5.25e-05	0.000731	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—PSEN2—dilated cardiomyopathy	5.21e-05	0.000726	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—RAF1—dilated cardiomyopathy	5.18e-05	0.000722	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ANKRD1—dilated cardiomyopathy	5.17e-05	0.000721	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	5.16e-05	0.000718	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	5.14e-05	0.000715	CbGpPWpGaD
Zonisamide—CA13—Metabolism—CD36—dilated cardiomyopathy	5.12e-05	0.000713	CbGpPWpGaD
Zonisamide—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	4.99e-05	0.000695	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—EGFR—dilated cardiomyopathy	4.98e-05	0.000693	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—ITGB1—dilated cardiomyopathy	4.97e-05	0.000693	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ANKRD1—dilated cardiomyopathy	4.96e-05	0.000691	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—ITGB1—dilated cardiomyopathy	4.93e-05	0.000687	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TAZ—dilated cardiomyopathy	4.87e-05	0.000678	CbGpPWpGaD
Zonisamide—SCN3A—L1CAM interactions—EGFR—dilated cardiomyopathy	4.77e-05	0.000665	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ANKRD1—dilated cardiomyopathy	4.76e-05	0.000663	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—ITGB1—dilated cardiomyopathy	4.74e-05	0.00066	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	4.74e-05	0.00066	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TAZ—dilated cardiomyopathy	4.66e-05	0.00065	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ANKRD1—dilated cardiomyopathy	4.66e-05	0.00065	CbGpPWpGaD
Zonisamide—CA13—Metabolism—AGT—dilated cardiomyopathy	4.61e-05	0.000642	CbGpPWpGaD
Zonisamide—SCN2A—L1CAM interactions—EGFR—dilated cardiomyopathy	4.58e-05	0.000639	CbGpPWpGaD
Zonisamide—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	4.58e-05	0.000639	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—ITGB1—dilated cardiomyopathy	4.57e-05	0.000637	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—CD36—dilated cardiomyopathy	4.48e-05	0.000624	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TAZ—dilated cardiomyopathy	4.47e-05	0.000623	CbGpPWpGaD
Zonisamide—SCN1A—L1CAM interactions—EGFR—dilated cardiomyopathy	4.42e-05	0.000616	CbGpPWpGaD
Zonisamide—CA4—Metabolism—SDHA—dilated cardiomyopathy	4.4e-05	0.000613	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TAZ—dilated cardiomyopathy	4.39e-05	0.000611	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—RAC1—dilated cardiomyopathy	4.36e-05	0.000607	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	4.35e-05	0.000606	CbGpPWpGaD
Zonisamide—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	4.25e-05	0.000592	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—CD36—dilated cardiomyopathy	4.24e-05	0.000591	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—RAC1—dilated cardiomyopathy	4.22e-05	0.000588	CbGpPWpGaD
Zonisamide—CA2—Metabolism—SDHA—dilated cardiomyopathy	4.22e-05	0.000588	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—RAC1—dilated cardiomyopathy	4.22e-05	0.000588	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—SOD2—dilated cardiomyopathy	4.2e-05	0.000585	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ANKRD1—dilated cardiomyopathy	4.18e-05	0.000583	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—EGFR—dilated cardiomyopathy	4.18e-05	0.000582	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—EGFR—dilated cardiomyopathy	4.18e-05	0.000582	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	4.15e-05	0.000577	CbGpPWpGaD
Zonisamide—CA1—Metabolism—SDHA—dilated cardiomyopathy	4.04e-05	0.000563	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—GPX1—dilated cardiomyopathy	4.01e-05	0.000558	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—RAC1—dilated cardiomyopathy	4e-05	0.000557	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—TNF—dilated cardiomyopathy	3.98e-05	0.000554	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—TNF—dilated cardiomyopathy	3.98e-05	0.000554	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—SDHA—dilated cardiomyopathy	3.97e-05	0.000553	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—RAC1—dilated cardiomyopathy	3.96e-05	0.000552	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ANKRD1—dilated cardiomyopathy	3.94e-05	0.000549	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TAZ—dilated cardiomyopathy	3.93e-05	0.000548	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—RAF1—dilated cardiomyopathy	3.92e-05	0.000546	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—ITGB1—dilated cardiomyopathy	3.87e-05	0.000539	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—EGFR—dilated cardiomyopathy	3.82e-05	0.000532	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	3.81e-05	0.000531	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—RAC1—dilated cardiomyopathy	3.81e-05	0.000531	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	3.77e-05	0.000525	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—ITGB1—dilated cardiomyopathy	3.75e-05	0.000522	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—RAF1—dilated cardiomyopathy	3.72e-05	0.000518	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TAZ—dilated cardiomyopathy	3.71e-05	0.000516	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.68e-05	0.000513	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—RAC1—dilated cardiomyopathy	3.67e-05	0.000512	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	3.66e-05	0.000511	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—TNF—dilated cardiomyopathy	3.64e-05	0.000507	CbGpPWpGaD
Zonisamide—CA9—Metabolism—SDHA—dilated cardiomyopathy	3.56e-05	0.000495	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—EGFR—dilated cardiomyopathy	3.55e-05	0.000495	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.52e-05	0.00049	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—TNF—dilated cardiomyopathy	3.38e-05	0.000471	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.38e-05	0.000471	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.38e-05	0.000471	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SDHA—dilated cardiomyopathy	3.35e-05	0.000467	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—CD36—dilated cardiomyopathy	3.3e-05	0.00046	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.26e-05	0.000454	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	3.21e-05	0.000448	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—CD36—dilated cardiomyopathy	3.2e-05	0.000445	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	3.14e-05	0.000437	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—RAC1—dilated cardiomyopathy	3.11e-05	0.000433	CbGpPWpGaD
Zonisamide—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	3.11e-05	0.000433	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—RAC1—dilated cardiomyopathy	3.01e-05	0.00042	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	3e-05	0.000418	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	2.96e-05	0.000412	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—RAF1—dilated cardiomyopathy	2.89e-05	0.000403	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	2.88e-05	0.000402	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	2.88e-05	0.000402	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	2.83e-05	0.000394	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—RAF1—dilated cardiomyopathy	2.8e-05	0.00039	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—RAF1—dilated cardiomyopathy	2.8e-05	0.00039	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	2.78e-05	0.000387	CbGpPWpGaD
Zonisamide—CA3—Metabolism—GPX1—dilated cardiomyopathy	2.76e-05	0.000384	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	2.75e-05	0.000383	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	2.72e-05	0.000379	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	2.72e-05	0.000379	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—EGFR—dilated cardiomyopathy	2.69e-05	0.000374	CbGpPWpGaD
Zonisamide—CA3—Metabolism—CD36—dilated cardiomyopathy	2.69e-05	0.000374	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—RAF1—dilated cardiomyopathy	2.65e-05	0.000369	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	2.63e-05	0.000366	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.63e-05	0.000366	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	2.62e-05	0.000365	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	2.58e-05	0.00036	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—EGFR—dilated cardiomyopathy	2.55e-05	0.000355	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	2.53e-05	0.000352	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	2.53e-05	0.000352	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ANKRD1—dilated cardiomyopathy	2.47e-05	0.000345	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.47e-05	0.000344	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	2.44e-05	0.000339	CbGpPWpGaD
Zonisamide—AOX1—Disease—NPPA—dilated cardiomyopathy	2.42e-05	0.000338	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AGT—dilated cardiomyopathy	2.42e-05	0.000337	CbGpPWpGaD
Zonisamide—AOX1—Disease—PSEN2—dilated cardiomyopathy	2.35e-05	0.000327	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TAZ—dilated cardiomyopathy	2.33e-05	0.000324	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	2.29e-05	0.000319	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SDHA—dilated cardiomyopathy	2.1e-05	0.000293	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—RAF1—dilated cardiomyopathy	2.06e-05	0.000287	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.01e-05	0.00028	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—RAF1—dilated cardiomyopathy	2e-05	0.000278	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—EGFR—dilated cardiomyopathy	1.98e-05	0.000276	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	1.96e-05	0.000273	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	1.96e-05	0.000272	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—EGFR—dilated cardiomyopathy	1.92e-05	0.000267	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—EGFR—dilated cardiomyopathy	1.92e-05	0.000267	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	1.88e-05	0.000263	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	1.88e-05	0.000261	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	1.84e-05	0.000257	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TNF—dilated cardiomyopathy	1.83e-05	0.000254	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—EGFR—dilated cardiomyopathy	1.82e-05	0.000253	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	1.8e-05	0.000251	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	1.8e-05	0.000251	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	1.8e-05	0.000251	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.8e-05	0.000251	CbGpPWpGaD
Zonisamide—CA14—Metabolism—GPX1—dilated cardiomyopathy	1.78e-05	0.000248	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	1.74e-05	0.000242	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—GPX1—dilated cardiomyopathy	1.73e-05	0.000241	CbGpPWpGaD
Zonisamide—CA6—Metabolism—GPX1—dilated cardiomyopathy	1.73e-05	0.000241	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	1.73e-05	0.000241	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	1.73e-05	0.000241	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CD36—dilated cardiomyopathy	1.73e-05	0.000241	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TNF—dilated cardiomyopathy	1.73e-05	0.000241	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	1.71e-05	0.000239	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CD36—dilated cardiomyopathy	1.69e-05	0.000235	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CD36—dilated cardiomyopathy	1.69e-05	0.000235	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	1.67e-05	0.000233	CbGpPWpGaD
Zonisamide—CA7—Metabolism—GPX1—dilated cardiomyopathy	1.62e-05	0.000225	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—GPX1—dilated cardiomyopathy	1.62e-05	0.000225	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CD36—dilated cardiomyopathy	1.58e-05	0.00022	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CD36—dilated cardiomyopathy	1.58e-05	0.00022	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AGT—dilated cardiomyopathy	1.56e-05	0.000217	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AGT—dilated cardiomyopathy	1.52e-05	0.000212	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AGT—dilated cardiomyopathy	1.52e-05	0.000212	CbGpPWpGaD
Zonisamide—CA12—Metabolism—GPX1—dilated cardiomyopathy	1.5e-05	0.000209	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CD36—dilated cardiomyopathy	1.46e-05	0.000203	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.44e-05	0.0002	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AGT—dilated cardiomyopathy	1.42e-05	0.000198	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AGT—dilated cardiomyopathy	1.42e-05	0.000198	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—EGFR—dilated cardiomyopathy	1.41e-05	0.000197	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—RAF1—dilated cardiomyopathy	1.38e-05	0.000192	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—EGFR—dilated cardiomyopathy	1.37e-05	0.000191	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TNF—dilated cardiomyopathy	1.35e-05	0.000188	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	1.34e-05	0.000187	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AGT—dilated cardiomyopathy	1.31e-05	0.000183	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TNF—dilated cardiomyopathy	1.3e-05	0.000182	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	1.29e-05	0.000179	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	1.28e-05	0.000178	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	1.24e-05	0.000172	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	1.24e-05	0.000172	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	1.23e-05	0.000171	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	1.22e-05	0.00017	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GPX1—dilated cardiomyopathy	1.2e-05	0.000167	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	1.19e-05	0.000166	CbGpPWpGaD
Zonisamide—AOX1—Disease—RAC1—dilated cardiomyopathy	1.18e-05	0.000164	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	1.18e-05	0.000164	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	1.18e-05	0.000164	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	1.17e-05	0.000164	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.17e-05	0.000163	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CD36—dilated cardiomyopathy	1.16e-05	0.000162	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GPX1—dilated cardiomyopathy	1.15e-05	0.00016	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	1.14e-05	0.000158	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CD36—dilated cardiomyopathy	1.12e-05	0.000155	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.1e-05	0.000153	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GPX1—dilated cardiomyopathy	1.1e-05	0.000153	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GPX1—dilated cardiomyopathy	1.08e-05	0.00015	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CD36—dilated cardiomyopathy	1.07e-05	0.000149	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CD36—dilated cardiomyopathy	1.05e-05	0.000146	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AGT—dilated cardiomyopathy	1.05e-05	0.000146	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AGT—dilated cardiomyopathy	1e-05	0.00014	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	9.95e-06	0.000139	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GPX1—dilated cardiomyopathy	9.66e-06	0.000135	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AGT—dilated cardiomyopathy	9.63e-06	0.000134	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AGT—dilated cardiomyopathy	9.45e-06	0.000132	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CD36—dilated cardiomyopathy	9.41e-06	0.000131	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GPX1—dilated cardiomyopathy	9.1e-06	0.000127	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CD36—dilated cardiomyopathy	8.87e-06	0.000124	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AGT—dilated cardiomyopathy	8.47e-06	0.000118	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	8.38e-06	0.000117	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AGT—dilated cardiomyopathy	7.98e-06	0.000111	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	7.98e-06	0.000111	CbGpPWpGaD
Zonisamide—AOX1—Disease—RAF1—dilated cardiomyopathy	7.83e-06	0.000109	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	7.04e-06	9.81e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.62e-06	9.22e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.07e-06	8.46e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.99e-06	8.34e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.91e-06	8.24e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GPX1—dilated cardiomyopathy	5.71e-06	7.96e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CD36—dilated cardiomyopathy	5.56e-06	7.75e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—dilated cardiomyopathy	5.37e-06	7.48e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.32e-06	7.42e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AGT—dilated cardiomyopathy	5.01e-06	6.98e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.7e-06	3.77e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.63e-06	3.67e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.37e-06	3.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.63e-06	2.27e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.58e-06	2.21e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.43e-06	1.99e-05	CbGpPWpGaD
